---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-001606"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:59:14.415374+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Pelthos Therapeutics posts corporate presentation; no specific material updates disclosed

## Summary
- Corporate presentation for Q4 2025 made available on company website on October 14, 2025.
- No financial results, guidance, or product-specific updates provided in the filing text.
- The exhibit text is truncated, precluding identification of any material developments.
- Presentation furnished under Regulation FD and not incorporated by reference into SEC filings.

## SEC filing metadata
- accession: 0001753926-25-001606
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001606/0001753926-25-001606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001606/g084975_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-001606
- JSON: https://secwatch.observer/filing/0001753926-25-001606.json
- Plain text: https://secwatch.observer/filing/0001753926-25-001606.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.